Amphotericin B (AmB), a broad-spectrum polyene antibiotic in the clinic for more than fifty
years, remains the gold standard in the treatment of life-threatening invasive fungal …

A widely established prodrug strategy can effectively optimize the unappealing properties of
therapeutic agents in cancer treatment. Among them, lipidic prodrugs extremely uplift the …

Peptic ulcer disease (PUD) is one of the most prevalent gastro intestinal disorder which
often leads to painful sores in the stomach lining and intestinal bleeding. Untreated …

Amphotericin B (AmB) is a potent polyenic antifungal agent with leishmanicidal activity. Due
to its low solubility and permeability in the gastrointestinal tract, AmB is usually administered …

Amphotericin B (AmB) is regarded as a first-line therapy against life-threatening invasive
fungal infections. Due to its poor oral bioavailability, AmB is restricted to intravenous …

In the present work, single wall carbon nanotubes (SWCNT) were successively
functionalized with phospholipid DSPE-PEG carboxylic acid, and then, with ethylenediamine …

The design and development of new pharmaceutical formulations for the existing anti-
leishmanial is a new strategic alternate to improve efficacy and safety rather than new drug …

Amphotericin B (AmpB) is a polyene macrolide antibiotic used in the treatment of blood-
borne parasitic and fungal infections. However, its use, particularly in the developing world …

The currently available systemic chemotherapy for treating breast cancer often results in
serious systemic side effects and compromises patient compliance. The distinct anatomical …

Leishmaniasis, a neglected tropical disease caused by Leishmania parasites, continues to
pose global health challenges. Current treatments face issues like resistance, safety …